Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 180,362 | 230,276 | 118,998 | 171,943 | 394,585 |
| Marketable Securities | 127,348 | 77,819 | 143,554 | 129,079 | 37,713 |
| Receivables | 802,638 | 693,120 | 601,271 | 435,380 | 238,347 |
| Inventories | N/A | 28,638 | N/A | N/A | N/A |
| Income taxes - deferred | 99,632 | 148,134 | N/A | N/A | N/A |
| TOTAL | $1,307,122 | $1,206,012 | $948,603 | $769,193 | $696,915 |
| Non-Current Assets | |||||
| PPE Net | 392,378 | 379,940 | 372,917 | 372,278 | 369,959 |
| Investments And Advances | 346,607 | 271,230 | 312,600 | 288,321 | 254,738 |
| Other Non-Current Assets | 229,891 | 223,308 | 26,495 | 27,708 | 28,547 |
| TOTAL | $968,876 | $874,478 | $712,012 | $688,307 | $653,244 |
| Total Assets | $2,275,998 | $2,080,490 | $1,660,615 | $1,457,500 | $1,350,159 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 145,413 | 111,345 | 124,224 | 126,768 | 106,723 |
| TOTAL | $197,244 | $163,550 | $178,568 | $183,220 | $160,386 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 50,358 | 50,831 | 53,067 | 55,269 | 52,570 |
| Other Non-Current Liabilities | 311,054 | 303,777 | 297,946 | 292,753 | 287,661 |
| TOTAL | $672,406 | $671,555 | $676,023 | $679,623 | $685,749 |
| Total Liabilities | $869,650 | $835,105 | $854,591 | $862,843 | $846,135 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,966 | 97,451 | 96,560 | 96,045 | 95,122 |
| Common Shares | 97 | 97 | 96 | 96 | 95 |
| Retained earnings | -418,180 | -517,054 | -987,461 | -1,178,929 | -1,255,672 |
| Other shareholders' equity | -1,644 | -1,166 | -1,904 | -2,371 | -1,337 |
| TOTAL | $1,406,348 | $1,245,385 | $806,024 | $594,657 | $504,024 |
| Total Liabilities And Equity | $2,275,998 | $2,080,490 | $1,660,615 | $1,457,500 | $1,350,159 |